Cargando…
A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections
BACKGROUND: Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated 5 to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated cellular blood components. HTLV-associated syndromes are considered as neglected diseases...
Autores principales: | Marqué, Lola, Liehl, Peter, De Boer, Jasper, Pottel, Hans, Murphy, Edward L., Bruhn, Roberta, Stone, Mars, Kaidarova, Zhanna, Lee, Tzong-Hae, Busch, Michael, Zrein, Maan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584783/ https://www.ncbi.nlm.nih.gov/pubmed/34724004 http://dx.doi.org/10.1371/journal.pntd.0009925 |
Ejemplares similares
-
Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease
por: Granjon, Elodie, et al.
Publicado: (2016) -
Telomere length, proviral load and neurologic impairment in HTLV-1-and HTLV-2-infected humans
por: Usadi, Benjamin, et al.
Publicado: (2014) -
Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects
por: Usadi, Benjamin, et al.
Publicado: (2016) -
HTLV-I and –II seroprevalence among United States blood donors, 2000-2009
por: Kaidarova, Zhanna, et al.
Publicado: (2011) -
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
por: Francisco, Amanda Fortes, et al.
Publicado: (2022)